Siraj M. Ali

Molecular Biology · 2002–2018

A researcher in the Science corpus: 9 papers; trusts 4 researchers and is trusted by 32 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 94 citations into it; #1,175 of 17,773 by trust here, #880 by citations

Whom Siraj M. Ali trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Dos D. Sarbassov

Who trusts Siraj M. Ali overall

1. David M. Sabatini
2. M. Laplante
3. D. Guertin
4. Dos D. Sarbassov
5. R. A. Saxton
6. Timothy R. Peterson
7. Y. Sancak
8. Shomit Sengupta
9. A. Budanov
10. R. Loewith

Papers from Siraj M. Ali's perspective

Ordered by how strongly the researchers Siraj M. Ali trusts endorse each paper. Same corpus, a different order for every researcher.

1. TOR, a central controller of cell growth. (Cell)
2. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
3. TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
4. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. (Genes & Development)
5. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells (Nature)
6. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. (Genes & Development)
7. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
8. Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling (Nature Cell Biology)
9. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
10. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy (Oncogene)

Their papers

• mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (2002) — 3,106 citations
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (2005) — 5,749 citations
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (2006) — 2,823 citations
• Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (2004) — 2,819 citations
• Growing roles for the mTOR pathway. (2005) — 1,640 citations
• GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. (2003) — 1,012 citations
• STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma (2018) — 1,344 citations
• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden (2017) — 3,045 citations
• Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. (2015) — 714 citations